The Biostatistics Shared Resource supports the spectrum of cancer-related research activities, including: experimental design, sample size calculation, randomization, analysis plans, data analysis, grant and manuscript preparation, full clinical trial support, and innovative targeted methods development.

This multidisciplinary facility provides access to human stem cells, 3D organoids, and other human-relevant disease models to support more predictive drug discovery, improved safety and toxicity assessment, and deeper mechanistic insight. Leveraging organoid and microphysiological platforms, the core enables next-generation therapeutics and “clinical trial-in-a-dish” approaches that advance biomedical innovation and precision medicine.

For information, email: organoids@mcw.edu

The MCW Cancer Center Cell Therapy Shared Resource (CTSR) focuses on curing cancer through innovative and effective cell therapies. The CTSR provides 1) state-of-art processing and production of cell therapy products for clinical use, 2) expertise in the translation of cellular therapies to the clinic, and 3) cutting-edge instrumentation supporting the development of novel immunotherapy strategies and insights on mechanisms of action for effective therapies.

The SBSR consists of the Protein Purification unit and the Structure Determination unit. The Protein Purification unit produces homogeneous, high-quality proteins well suited for downstream biophysical studies and structure determination. The Structure Determination unit employs X-ray crystallography, Cryo-EM, and advanced AI-assisted analytical tools for structure determination and imaging.